Liftstream announces attendance at World Orphan Drug Congress – Europe 2014
22 July 2014
On 22nd July 2014 Liftstream Ltd, the Life Sciences Executive Search and Interim Management Company, announced its attendance of the World Orphan Drug Congress – Europe, in Brussels on November 12th – 14th 2014.
Liftstream Founder & CEO, Karl Simpson, said ‘Liftstream is once again proud to attend the World Orphan Drug Congress for 2014. The field of rare diseases and orphan drugs continues to be at the heart of Liftstream’s business and it is important to stay connected with companies and patient organisations in the space.’
He added, “Once again rare diseases have been at the heart of the industry conversation. This conference allows Liftstream to be at the heart of the conversation and support our rare disease industry clients recruit the executives who are able to contribute to this patient-centric area of our industry.’
The World Orphan Drug Congress is one of several events run by conference producers Terrapinn. It hosts over 500 biotech executives, investors and providers looking to find new relationships to build their ventures with a specific focus on rare diseases and orphan drugs.
Liftstream is a privately owned company that provides Executive Search and Interim Management recruitment services to the pharmaceutical, biotechnology and life sciences markets across Europe. Liftstream also works with senior managers and executives to provide highly structured career management services that enable more effective career performance.
Back to news and press releases